☆ 4.7 Editorial Material

Targeting Inflammation in the Prevention and Treatment of Type 2 Diabetes Insights From CANTOS

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)

Get Full Text
Add to Collection

Journal

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Volume 71, Issue 21, Pages 2402-2404

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2018.03.480

Keywords

atherosclerosis; diabetes; inflammation

Categories

Cardiac & Cardiovascular Systems

Funding

  1. Abbott
  2. Amgen
  3. AstraZeneca
  4. Bayer
  5. Boehringer Ingelheim
  6. Bristol-Myers Squibb/Pfizer
  7. Eli Lilly
  8. Janssen
  9. Merck
  10. Novartis
  11. Novo Nordisk
  12. Sanofi
  13. Valeant

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.